Xpert

HCV
Viral Load

It’s a New Day for Patient Management

Xpert HCV Viral Load ®

Ultrasensitve Results for Effective Treatment

A better way.
In Vitro Diagnostic Medical Device
Cepheid’s Xpert® HCV Viral Load test delivers results in hours rather than days —
with the simplicity and ease of use of a point-of-care test. It is a very sensitive test
for confirmation of infection and monitoring of HCV, and will assist in better patient
management.”
Pr. Jean-Michel Pawlotsky M.D., Ph.D.
Professor of Medicine at the University of Paris-Est
Director of the National Reference Center for Viral Hepatitis B,
C and Delta
Director of the Department of Virology at the Henri Mondor
University Hospital in Créteil, France
Director of the Department of Molecular Virology and
Immunology at the Institut Mondor de Recherche Biomédicale

THE NEED THE SOLUTION

An estimated 185 million people, 3% of the world’s Xpert HCV Viral Load is a quantitative test that provides
population, have been infected with HCV.1 Each year, on-demand molecular testing for diagnosis* and
350,000 to 500,000 people die from HCV-related monitoring of HCV.
liver disease.2 Based on the GeneXpert technology, Xpert HCV Viral
The primary objective of anti-HCV treatment is the Load utilises automated reverse transcriptase polymerase
Sustained Virologic Response (SVR), defined as chain reaction (RT-PCR) using fluorescence to detect and
undetectable HCV RNA by a sensitive test 12 or 24 weeks quantify RNA.
after the end of treatment.3 With increasing numbers of Xpert HCV Viral Load quantifies HCV genotypes 1–6 over the
patients achieving SVR following treatment, eradication of range of 10 to 100,000,000 IU/mL.
HCV is being discussed for the first time.4
Redefining Simple
Existing HCV viral load tests are complicated to use,
Ultrasensitive
require complex technical settings and highly trained
• LOD of 4.0 IU/mL in EDTA plasma (95% CI 2.8 – 5.2)^
technicians to operate.
• LOD of 6.1 IU/mL in serum (95% CI 4.2 – 7.9)^
An ultrasensitive, easy to use HCV viral load test with
Easy
the flexibility to adapt to any throughput is critical as a
• <1 minute hands-on time
companion test for newly developed drug regimens.
• Run daily or on-demand
• No requirements for PCR room settings
• No daily maintenance or liquid waste management
Flexible
• 105 minutes run time with a viral load trend report#
• Compatible with any lab volume
* Interpretation in conjunction with other clinical and laboratory • Providing up to 345 viral load results per 8 hours†
findings.
^
HCV genotype 1 (WHO 4th International standard).
• Random access 24/7 availability
#
Trend report available for patients’ viral load measured multiple • Fixed cost per reportable result independent of daily volume
times on the same GeneXpert.
†
Operational throughput on Infinity-80; internal analysis.
 THE IMPACT
• Improve Patient Care: Same day results support better clinical decisions

• Increase Efficiency: Highly sensitive quantitative viral loads of HCV enable earlier adjustments to therapy

• Strengthen Communities: Quick decisions can help reduce transmission

Move your lab forward

• No Waiting: Deliver individual patient results when they’re most needed

• Simple & Organised: True 24/7 random access accommodates other urgent test requests

• Flexible: Adapt to any throughput requirement

• Improve Service: Run more than one test simultaneously

PERFORMANCE
A multi-site study was conducted to evaluate the performance of Xpert® HCV Viral Load relative to a comparator method
using fresh and frozen human plasma specimens collected from HCV infected individuals. Of the 607 specimens, 389 were
within the quantitation range of the both assays including 23 specimens that were HCV non-1 genotypes (2, 2a, 2b, 2c, 3,
3a, 4 & 6) and one mixed genotype (HCV 1 & 6).

The limit of detection (LOD) of the HCV VL was determined by testing eight different dilutions prepared from a HCV
genotype 1 reference standard in HCV negative EDTA plasma and serum with 3 reagents lots. The HCV RNA concentration
that can be detected with a positivity rate of greater than 95% was determined by Probit regression analysis.
• The maximum observed LOD with Probit analysis for HCV genotype 1 in EDTA plasma is 4.0 IU/mL (95% CI 2.8 – 5.2)
• The maximum observed LOD with Probit analysis for HCV genotype 1 in serum is 6.1 IU/mL (95% CI 4.2 – 7.9)

XPERT V. COMPARATOR (LOG IU/ML) Concentration Positivity

Specimen (IU/mL) Rate (%)
8
0.5a 49
Deming Reg: y = 1.022x - 0.082
7 1 65
R2 = 0.986
2 85
6
WHO 3 96
5 (Plasma)
Xpert Value

4 93
6 99
4
8 100
3 LogXpert 10 100
Non-1
0.5a 40
2
No Bias Line
1 64
1 DemReg Overall
2 88
Linear (LogXpert)
WHO 3 96
0
0 1 2 3 4 5 6 7 8 (Serum) 4 97
Comparator Value
6 99
HCV non-1 genotypes are represented as triangles. A single outlier was not included in the analysis.
8 97
10 100

a. 0.5 IU/mL was added day 2 due to the

high positivity rate observed at 1 IU/mL
after day 1
WORKFLOW:

2 Easy Steps System Throughput* 345

Total hands-on time: <1 minute 8-hr shift

212

1 Transfer at least 1 mL of
plasma or serum into the
72

9 18
cartridge
GX-II GX-IV GX-XVI Infinity-48 Infinity-80

* Operational throughput per 8-hr shift based on HCV Viral Load testing,
internal analysis.

2 Scan, load cartridge and

start test

Xpert® HCV Viral Load provides reliable, on-demand results in less than 2 hours.
CATALOG INFORMATION

Xpert HCV Viral Load (10 tests) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . GXHCV-VL-CE-10

References:
1. Mohd Hanafiah K, et al. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 2013; 57(4): 1333-42.
2. WHO. Hepatitis C Fact Sheet N° 164. Updated April 2014. Accessed April 2015 at http://www.who.int/mediacentre/factsheets/fs164/en/
3. Ghany MG, et al. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009 Apr;49 (4):1335-74.
4. Graham CS, et al. A Path to Eradication of Hepatitis C in Low-and-Middle-Income Countries. Antiviral Res. 2015 Jan 20; pii: S0166-3542(15)00005-4. [Epub ahead of print].

CORPORATE HEADQUARTERS EUROPEAN HEADQUARTERS www.Cepheidinternational.com

904 Caribbean Drive Vira Solelh
Sunnyvale, CA 94089 USA 81470 Maurens-Scopont France
+1.888.336.2743
TOLL FREE PHONE +33.563.82.53.00
PHONE +1.408.541.4191 FAX +33.563.82.53.01
FAX +1.408.541.4192 EMAIL cepheid@cepheideurope.fr

3043-02